The neuroprotective effect of picroside II from Hu-Huang-lian against oxidative stress

American Journal of Chinese Medicine

Volumn 35, Issue 4, 2007, Pages 681-691

  Li, Ting ^a   Liu, Jian Wen ^a   Zhang, Xiao Dong ^a   Guo, Ming Chuan ^a   Ji, Guang ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Aluminium; Glutamate; Hu Huang Lian; Neuroprotection; Oxidative Stress; Pricroside II

Indexed keywords

ALUMINUM CHLORIDE; CHINESE DRUG; DNA FRAGMENT; GLUTAMIC ACID; HU HUANG LIAN; HUPERZINE A; PICROSIDE II; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG STRUCTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS;

ADRENAL GLAND NEOPLASMS; ALUMINUM COMPOUNDS; ANIMALS; APOPTOSIS; CELL SURVIVAL; CHLORIDES; CINNAMATES; DRUGS, CHINESE HERBAL; GLUCOSIDES; GLUTAMATES; LEARNING; MALE; MEDICINE, CHINESE TRADITIONAL; MEMORY DISORDERS; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; PC12 CELLS; PHEOCHROMOCYTOMA; PHYTOTHERAPY; RANDOM ALLOCATION; RATS;

EID: 34548166265     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X0700517X     Document Type: Article

References (28)

1. Atlante, A., P. Calissano, A. Bobba, S. Giannattasio, E. Marra and S. Passarella. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497: 1-5, 2001.
2. Bastianetto, S. and R. Quirion. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 23: 891-897, 2002.
3. Behl, C. and B. Moosmann. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach., Free Radic. Biol. Med 33: 182-191, 2002.
4. Campbell, A., K.M. Prasad and S.C. Bondy. Aluminium-induced oxidative events in cell lines: Gliomas are more responsive than neuroblastoma. Free Radic. Biol. Med. 26: 1166-1171, 1999.
5. Christen, Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71: 621S-629S, 2000.
6. Deng, Z., C. Coudray, L. Gouzoux, A. Mazur, Y. Rayssiguier and D. Pepin. Effect of oral aluminium and aluminium citrate on blood level and short-term tissue distribution of aluminium in the rat. Biol. Trace Elem. Res. 63: 139-147, 1998.
7. Emerit, J., M. Edeas and F. Bricaire. Neurodegenerative disease and oxidative stress. Biomed. Pharmacother. 58: 39-46, 2004.
8. Erasmus, R.T., J. Savory, M.R. Wills and M.M. Herman. Aluminium neurotoxicity in experimental animals. Ther. Drug Monit. 15: 588-592, 1993.
9. Froissard, P. and D. Duval. Cytotoxic effects of glutamic acid on PC12 cells. Neurochem. Int. 24: 485-493, 1994.
10. Ganrot, P.O. Metabolism and possible health effects of aluminium. Environ. Health Perspect. 65: 363-441, 1986.
11. Gao H. and Y.W. Zhou. Inhibitory effect of picroside II on hepatocyte apoptosis. Acta Pharmacol. Sin. 26: 729-736, 2005.
12. Greyer, J.L. and C.F. Powers. Assessment of exposure to parenteral and oraf aluminium with and without citrate using a deferrioxamine test in rats. Toxicology 76: 119-132, 1992.
13. Hewitt, C.D., J. Savory and M.R. Wills. Aspects of aluminium toxicity. Clin. Lab. Med. 10: 403-422, 1990.
14. Hirsch, E.C. Biochemistry of Parkinson's disease with special reference to the dopaminergic systems. Mol. Neurobiol. 9: 135-142, 1994.
15. Hockenbery, D., G. Nunez, C. Milliman, R.D. Schreiber and S.J. Korsmeyer. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990.
16. Julka, D. and K.D. Gill. Effect of aluminium on regional brain antioxidant defense status in Wistar rats. Res. Exp. Med. (Berl.) 196: 187-194, 1996.
17. Li, P., K. Matsunaga, T. Yamakuni and Y. Ohizumi. Picrosides I and II, selective enhancers of the mitogen-activated protein kinase-dependent signaling pathway in the action of neuritogenic substances on PC12D cells. Life Sci. 71: 1821-1835, 2002.
18. Lione, A. Aluminium toxicology and the aluminium-containing medications. Pharmacol. Ther. 29: 255-285, 1985.
19. Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11: 47-60, 1984.
20. Mossman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63, 1983.
21. Murphy, T.H., M. Miyamoto, A. Sastre, R.L. Schnaar and J.T. Coyle. Glutamate toxicity in a neural cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2: 1547-1558, 1989.
22. Pereira, C.M. and C.R. Oliveira. Glutamate toxicity on PC12 cell line involves glutathione (GSH) depletion and oxidative stress. Free Radic. Biol. Med. 23: 637-647, 1997.
23. Savory, J., C. Exley, W.F. Forbes, Y. Huang, J.G. Joshi, T. Kruck, D.R. McLachlan and I. Wakayama. Can the controversy of the role of aluminium in Alzheimer's disease be resolved? What are the suggestive approaches to this controversy and methodological issues to be considered? J. Toxicol. Environ. Health 48: 615-635, 1996.
24. Seyfried, J., B.O. Evert, C. Rundfeldt, J.B. Schulz, K.A. Kovar, T. Klocgether and U. Wullner. Flupirtine and retigabine prevent 1-glutamate toxicity in rat pheochromocytoma PC12 cells. Eur. J. Pharmacol. 400: 155-166, 2000.
25. Sohal, R.S., R.J. Mockett and W.C. Orr. Mechanisms of aging: An appraisal of the oxidative stress hypothesis. Free Radic. Biol. Med. 33: 575-586, 2002.
26. Yokel, R.A. The toxicology of aluminium in the brain: A review. Neurotoxicology 21: 813-828, 2000.
27. Yokel, R.A. and P.J. McNamara. Aluminium toxicokinetics: An updated minireview. Pharmacol. Toxicol. 88: 159-167, 2001.
28. Zhu, X., A.K. Raina, H.G. Lee, G. Casadesus, M.A. Simith and G. Perry. Oxidative stress signaling in Alzheimer's disease. Brain Res. 1000: 32-39, 2004.